Background While it is now apparent clinical sequelae (long COVID) may persist after acute
COVID-19, their nature, frequency and aetiology are poorly characterised. This study aims to …

Background Monkeypox (MPX) is an important human Orthopoxvirus infection. There has
been an increase in MPX cases and outbreaks in endemic and non-endemic regions in recent …

Health consequences that persist beyond the acute infection phase of COVID-19, termed
post-COVID-19 condition (also commonly known as long COVID), vary widely and represent a …

Background A substantial portion of people with COVID-19 subsequently experience lasting
symptoms including fatigue, shortness of breath, and neurological complaints such as …

Although the majority of people with Covid-19 will experience mild to moderate symptoms
and will recover fully, there is now increasing evidence that a significant proportion will …

Background Chikungunya virus (CHIKV) has expanded its geographical reach in recent
decades and is an emerging global health threat. CHIKV can cause significant morbidity and …

The Sudan virus disease outbreak in Uganda in 2022 showed our vulnerability to viral
haemorrhagic fevers (VHFs). Although there are regular outbreaks of VHFs with high morbidity …

Background The COVID-19 pandemic has highlighted the importance of evidence-based
clinical decision-making. Clinical management guidelines (CMGs) may help reduce morbidity …

Post-COVID-19 condition (also known as long COVID) is a new, complex, and poorly
understood disorder. A core outcome set (COS) for post-COVID-19 condition in adults has been …

Background The clinical sequelae (Long Covid) of acute Covid-19 are recognised globally,
yet the risk of developing them is unknown. Methods A living systematic review (second …